Funding · Company
SELKIRK PHARMA, INC.
Spokane, WAIndustrial & Manufacturing
SELKIRK PHARMA, INC. of Spokane, WA has disclosed $59M across 2 Form D offerings filed with the SEC between Dec 30, 2021 and Sep 13, 2023.
$59M
Total disclosed
2
Form D offerings
2017
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$24M
Form D · Sep 13, 2023 ↗
Q3 2023
· target $25M
Filing details
HeadquartersSpokane, WAIndustryIndustrial & Manufacturing (Manufacturing)Incorporated2017SEC CIK0001732446Offerings on file2
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. Spot an error? Full methodology →